Wataru Omori
Hiroshima, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Electroconvulsive therapy in an older patient with recurrent major depressive disorder and a permanent pacemaker: A case report.
Journal: PCN reports : psychiatry and clinical neurosciences
Published: March 23, 2026
Epilepsy-Related Psychosis in Drug-Resistant Epilepsy With Nonconvulsive Status Epilepticus and Difficult Antipsychotic Titration: A Case Report.
Journal: Neuropsychopharmacology reports
Published: March 18, 2026
Pharmacological Re-Optimization With Venlafaxine in Two Elderly Patients With Severe Major Depressive Disorder Considered for Electroconvulsive Therapy: A Two-Patient Case Report.
Journal: Clinical case reports
Published: December 24, 2025
Ethanolamine as a potential biomarker and therapeutic target for depressive disorder.
Journal: Molecular psychiatry
Published: May 02, 2025
Identification of shared pathophysiological molecules of major psychiatric disorders: A comprehensive analysis of serum immune complex antigens before and after electroconvulsive therapy.
Journal: Journal of neuroimmunology
Published: January 29, 2025
Impact of COVID-19 on new pharmacotherapy for insomnia: A matched cohort study using the national insurance claims database in Japan.
Journal: PloS one
Published: January 16, 2025
Approaches for difficult-to-induce-seizures electroconvulsive therapy cases (DEC): a Japanese expert consensus.
Journal: Annals of general psychiatry
Published: October 16, 2024
Impact of COVID-19 on antidepressant prescription: a matched cohort study using the National insurance claims database in Japan.
Journal: BMC psychiatry
Published: October 10, 2024
Serum levels of high mobility group box-1 protein (HMGB1) and soluble receptors of advanced glycation end-products (RAGE) in depressed patients treated with electroconvulsive therapy.
Journal: Neuropsychopharmacology reports
Published: March 22, 2023
Tetraspanin heterogeneity of small extracellular vesicles in human biofluids and brain tissue.
Journal: Biochemical and biophysical research communications
Published: June 15, 2022
Reduced Cerebrospinal Fluid Levels of Lysophosphatidic Acid Docosahexaenoic Acid in Patients With Major Depressive Disorder and Schizophrenia.
Journal: The international journal of neuropsychopharmacology
Published: March 07, 2021
Last Updated: 09/26/2026